Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
* Sales estimated to be 87 million USD up 6% from Q3 last year * Operational profit estimated to be 15 million USD up 79% * Net profit estimated 12 million USD up 480% from Q3 last year * EBITDA estimated 20 million USD up 43%
At a Board of Directors meeting 10 October, it was decided to publish immediately outlook for Q3. This is done in light of highly unusual situation at the financial markets and in order to facilitate and enable primary insiders to trade their shares. The Financial Statements are in the process of being finalized. This outlook is based on actual performance for July and August and estimates for September. One-time other income includes USD 2 million due to milestone payment from the advanced wound care product line which was divested earlier this year.
For further details, see the press release in the attachment.
